Search Results for "Liquisolids Review"

17:36 EST 9th February 2016 | BioPortfolio

Matching Channels

Phosphodiesterase 4 PDE 4 Inhibitors

Phosphodiesterase 4 (PDE-4) inhibitors have attracted considerable interest as potential therapeutic agents for diseases including chronic obstructive pulmonary disease. PDE-4 inhibitors are known to ...

Breast Implants - Augmentation

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...

Matching News

Peer Review Week: An analysis of peer review style and quality

This week celebrates the first ever Peer Review Week; a collaborative concept from ORCID, Wiley, Sense About Science and ScienceOpen, to highlight and celebrate the invaluable role peer review plays i...

Open peer review could result in better quality of peer review

Whether or not a research article has been peer reviewed openly can seemingly make a difference to the quality of the peer review, according to research carried out by BioMed Central's Research Integr...

Week in Review: August 17?21

Synthetic DNA–based MERS vax shows promise; fake peer review on scores of papers; gut microbes and an autoimmune eye disease; “Informed Consent” theater review

BRIEF-FDA completes Biofrontera's Ameluz NDA mid-cycle review

* Review resulted in no additional requests for material nor were any additional review issues highlighted Source text for Eikon: Further company coverage: (Gdynia Newsroom)

AbbVie buys special review voucher for $350 mln

Aug 19 (Reuters) - AbbVie Inc has bought a priority review voucher from United Therapeutics Corp for $350 million that will allow it to accelerate the review process for one of its drugs.

Review of Priority Review Vouchers

This Viewpoint assesses the US Food and Drug Administration’s priority review voucher program to encourage development of drugs to treat neglected tropical diseases or rare pediatric disease and rec...

NDAs Face Rejection As China FDA Starts ‘Intensive Review’

In a rare move, the China FDA has rejected 11 new drug applications from eight companies that were in its review queue, signaling more action to come as the agency ups punishments for clinical data fo...

AbbVie Buys Last Available Priority Review Voucher For $350 Mil.; FDA Ready to Make More

Abbvie is paying $350 million for the right to a faster FDA review for a future application. That means that the value of a priority review voucher has quintupled in the past year.

Matching PubMed Articles

Peer Review Quality and Transparency of the Peer-Review Process in Open Access and Subscription Journals.

Recent controversies highlighting substandard peer review in Open Access (OA) and traditional (subscription) journals have increased the need for authors, funders, publishers, and institutions to assu...

The job of 'ethics committees'.

What should authorities establish as the job of ethics committees and review boards? Two answers are: (1) review of proposals for consistency with the duly established and applicable code and (2) revi...

More noise does not mean more precision: A review of Aldenberg and Rorije (2013).

This paper provides a critical review of recently published work that suggests that the precision of hazardous concentration estimates from Species Sensitivity Distributions (SSDs) is improved when th...

Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part I. General Guidance and Tips.

In the field of diagnostic test accuracy (DTA), the use of systematic review and meta-analyses is steadily increasing. By means of objective evaluation of all available primary studies, these two proc...

Book review: Reviewing the review.

Search Whole site using Google

Quick Search
Advertisement Advertisement